211 related articles for article (PubMed ID: 36196592)
1. Evaluation of urinary neutrophil gelatinase-associated lipocalin to detect renal tubular damage in dogs with stable myxomatous mitral valve disease.
Troia R; Sabetti MC; Crosara S; Quintavalla C; Romito G; Mazzoldi C; Fidanzio F; Cescatti M; Bertazzolo W; Giunti M; Dondi F
J Vet Intern Med; 2022 Nov; 36(6):2053-2062. PubMed ID: 36196592
[TBL] [Abstract][Full Text] [Related]
2. Association between echocardiographic indexes and urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL) in dogs with myxomatous mitral valve disease.
Crosara S; Fidanzio F; Oricco S; Dondi F; Mazzoldi C; Monari E; Romito G; Sabetti MC; Troìa R; Quintavalla C
Res Vet Sci; 2024 May; 171():105211. PubMed ID: 38458044
[TBL] [Abstract][Full Text] [Related]
3. Peripheral blood lymphocyte subtypes in dogs with different stages of myxomatous mitral valve disease.
Druzhaeva N; Nemec Svete A; Ihan A; Pohar K; Domanjko Petrič A
J Vet Intern Med; 2021 Sep; 35(5):2112-2122. PubMed ID: 34236111
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP) and their correlation with lipoproteins in dogs with myxomatous mitral valve disease.
Khaki Z; Nooshirvani P; Shirani D; Masoudifard M
BMC Vet Res; 2022 Dec; 18(1):448. PubMed ID: 36564735
[TBL] [Abstract][Full Text] [Related]
5. Iron parameters analysis in dogs with myxomatous mitral valve disease.
Kumiega E; A Kobak K; Noszczyk-Nowak A; Kasztura M
BMC Vet Res; 2024 May; 20(1):210. PubMed ID: 38762716
[TBL] [Abstract][Full Text] [Related]
6. Symmetric dimethylarginine in dogs with myxomatous mitral valve disease at various stages of disease severity.
Valente C; Guglielmini C; Domenech O; Contiero B; Zini E; Poser H
PLoS One; 2020; 15(9):e0238440. PubMed ID: 32870923
[TBL] [Abstract][Full Text] [Related]
7. Effect of sampling time on urinary electrolytes following oral furosemide administration in dogs with myxomatous mitral valve disease.
Sabetti MC; Fidanzio F; Troìa R; Perissinotto L; Romito G; Mazzoldi C; Quintavalla C; Crosara S; Dondi F
J Vet Cardiol; 2022 Jun; 41():57-69. PubMed ID: 35245876
[TBL] [Abstract][Full Text] [Related]
8. Urine neutrophil gelatinase-associated lipocalin to diagnose and characterize acute kidney injury in dogs.
Monari E; Troìa R; Magna L; Gruarin M; Grisetti C; Fernandez M; Balboni A; Giunti M; Dondi F
J Vet Intern Med; 2020 Jan; 34(1):176-185. PubMed ID: 31705606
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the diagnostic value of the renal resistive index as a marker of the subclinical development of cardiorenal syndrome in MMVD dogs.
Szczepankiewicz B; Pasławska U; Siwińska N; Plens K; Pasławski R
J Renin Angiotensin Aldosterone Syst; 2021; 22(1):1470320321995082. PubMed ID: 33730896
[TBL] [Abstract][Full Text] [Related]
10. Urinary neutrophil gelatinase-associated lipocalin as an early biomarker for acute kidney injury in dogs.
Scheemaeker S; Meyer E; Schoeman JP; Defauw P; Duchateau L; Daminet S
Vet J; 2020 Jan; 255():105423. PubMed ID: 31982082
[TBL] [Abstract][Full Text] [Related]
11. The classical and alternative circulating renin-angiotensin system in normal dogs and dogs with stage B1 and B2 myxomatous mitral valve disease.
Hammond HH; Ames MK; Domenig O; Scansen BA; Yang NT; Wilson MD; Sunshine E; Brunk K; Masters A
J Vet Intern Med; 2023; 37(3):875-886. PubMed ID: 36951394
[TBL] [Abstract][Full Text] [Related]
12. Urine 5-hydroxyindoleacetic acid in Cavalier King Charles spaniels with preclinical myxomatous mitral valve disease.
Christiansen LB; Cremer SE; Helander A; Madsen T; Reimann MJ; Møller JE; Höglund K; Ljungvall I; Häggström J; Olsen LH
Vet J; 2019 Aug; 250():36-43. PubMed ID: 31383418
[TBL] [Abstract][Full Text] [Related]
13. Proteomics reveals plasma protein SERPINH1 as a potential diagnostic biomarkers for myxomatous mitral valve disease stage B2.
Zhou Q; Wu Z; Li L; Zhou H; Chen Y; Guo S; Guo Y; Ma X; Zhang J; Feng W; Cui X; Qiu C; Xu M; Deng G
J Proteomics; 2023 Jun; 282():104924. PubMed ID: 37146676
[TBL] [Abstract][Full Text] [Related]
14. Severity of myxomatous mitral valve disease in dogs may be predicted using neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratio.
Ku D; Chae Y; Kim C; Koo Y; Lee D; Yun T; Chang D; Kang BT; Yang MP; Kim H
Am J Vet Res; 2023 Jun; 84(6):. PubMed ID: 37024099
[TBL] [Abstract][Full Text] [Related]
15. Urinary neutrophil gelatinase-associated lipocalin concentration changes after acute haemorrhage and colloid-mediated reperfusion in anaesthetized dogs.
Davis J; Raisis AL; Cianciolo RE; Miller DW; Shiel RE; Nabity MB; Hosgood GL
Vet Anaesth Analg; 2016 May; 43(3):262-70. PubMed ID: 26469528
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of serum cystatin C concentration in dogs with myxomatous mitral valve disease.
Iwasa N; Kumazawa R; Nomura S; Shimizu M; Iwata M; Hara M; Kawabe M; Kobatake Y; Takashima S; Nishii N
J Vet Intern Med; 2023 Mar; 37(2):412-419. PubMed ID: 36852471
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of endothelial cell-specific molecule-1 as a biomarker of glycocalyx damage in canine myxomatous mitral valve disease.
Hong HJ; Oh YI; Park SM; An JH; Kim TH; Chae HK; Seo KW; Youn HY
BMC Vet Res; 2022 Jul; 18(1):261. PubMed ID: 35790968
[TBL] [Abstract][Full Text] [Related]
18. Urinary neutrophil gelatinase-associated lipocalin in dogs with stable or progressive kidney disease.
Kim YM; Polzin DJ; Rendahl A; Granick JL
J Vet Intern Med; 2019 Mar; 33(2):654-661. PubMed ID: 30767290
[TBL] [Abstract][Full Text] [Related]
19. Correlation between serum homocysteine concentration and severity of mitral valve disease in dogs.
Lee CM; Jeong DM; Kang MH; Kim SG; Han JI; Park HM
Am J Vet Res; 2017 Apr; 78(4):440-446. PubMed ID: 28345991
[TBL] [Abstract][Full Text] [Related]
20. Serotonin concentrations in platelets, plasma, mitral valve leaflet, and left ventricular myocardial tissue in dogs with myxomatous mitral valve disease.
Cremer SE; Singletary GE; Olsen LH; Wallace K; Häggström J; Ljungvall I; Höglund K; Reynolds CA; Pizzinat N; Oyama MA
J Vet Intern Med; 2014; 28(5):1534-40. PubMed ID: 25146933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
